Date:
April 5, 2021
Issue #:
1621
Summary:
The centuries-old anti-inflammatory drug colchicine
(Colcrys, and others) is FDA-approved for prophylaxis
and treatment of gout flares and for treatment of
familial Mediterranean fever. It is also used off-label
to treat pericarditis, and in recent years has been
investigated for reduction of cardiovascular risk in
patients with coronary artery disease (CAD).
(Colcrys, and others) is FDA-approved for prophylaxis
and treatment of gout flares and for treatment of
familial Mediterranean fever. It is also used off-label
to treat pericarditis, and in recent years has been
investigated for reduction of cardiovascular risk in
patients with coronary artery disease (CAD).
